Figini Filippo, Chen Shao Liang, Sheiban Imad
Division of Cardiology, Ospedale "Pederzoli", Peschiera del Garda, Italy.
Division of Cardiology, Nanjing Medical University, Nanjing, China.
Heart Int. 2020 Dec 23;14(2):80-85. doi: 10.17925/HI.2020.14.2.80. eCollection 2020.
In recent years, practice and guidelines for patients with ST-elevation myocardial infarction (STEMI) have evolved from a 'culprit-only approach' to complete revascularisation; however, several issues remain, particularly regarding assessment of non-culprit lesions and timing of their revascularisation. Complete revascularisation should be performed in patients presenting with STEMI; however, available studies often present contradictory results regarding the optimal timing of non-culprit lesion percutaneous coronary intervention (PCI). The aim of this review is to provide a practical approach for the assessment of patients presenting with STEMI and multivessel coronary artery disease by analysing randomised trials, meta-analyses and our clinical experience. We recommend multivessel revascularisation at the time of primary PCI for simple cases, while we suggest deferring treatment of complex lesions; the optimal timing of staged PCI should be individualised according to clinical judgement.
近年来,ST段抬高型心肌梗死(STEMI)患者的治疗实践和指南已从“仅处理罪犯病变的方法”演变为完全血运重建;然而,仍存在一些问题,特别是在非罪犯病变的评估及其血运重建时机方面。STEMI患者应进行完全血运重建;然而,现有研究对于非罪犯病变经皮冠状动脉介入治疗(PCI)的最佳时机常常给出相互矛盾的结果。本综述的目的是通过分析随机试验、荟萃分析以及我们的临床经验,为STEMI和多支冠状动脉疾病患者的评估提供一种实用方法。对于简单病例,我们建议在直接PCI时进行多支血管血运重建,而对于复杂病变,我们建议推迟治疗;分期PCI的最佳时机应根据临床判断个体化。